1. Home
  2. RLAY vs RBCAA Comparison

RLAY vs RBCAA Comparison

Compare RLAY & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$9.72

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Republic Bancorp Inc.

RBCAA

Republic Bancorp Inc.

HOLD

Current Price

$68.11

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLAY
RBCAA
Founded
2015
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
RLAY
RBCAA
Price
$9.72
$68.11
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$14.50
N/A
AVG Volume (30 Days)
2.0M
28.6K
Earning Date
05-27-2026
05-01-2026
Dividend Yield
N/A
2.63%
EPS Growth
31.78
N/A
EPS
N/A
0.77
Revenue
$15,355,000.00
$384,804,000.00
Revenue This Year
N/A
$3.93
Revenue Next Year
$178.50
N/A
P/E Ratio
N/A
$89.21
Revenue Growth
53.44
6.82
52 Week Low
$1.78
$56.79
52 Week High
$11.43
$78.00

Technical Indicators

Market Signals
Indicator
RLAY
RBCAA
Relative Strength Index (RSI) 59.25 38.71
Support Level $7.22 $67.29
Resistance Level $11.43 $72.98
Average True Range (ATR) 0.68 2.23
MACD 0.04 -0.31
Stochastic Oscillator 43.23 24.97

Price Performance

Historical Comparison
RLAY
RBCAA

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: